Abstract
Background: Many different methods have been developed to incorporate hydrophobic compounds into polymeric micelles, including simple equilibrium (SE) and solvent casting (SC). Thus far, no studies have compared the SE and SC methods for drug loading and stability.
Methods: Resveratrol (RES), a model hydrophobic compound, loaded in various Pluronics® (F88, F98, F108, and F127) is used to determine the differences between SE and SC methods.
Results: Micelles prepared by SE method demonstrated RES loading in proportion to their respective CMC values with F127 having the lowest CMC and highest loading at Day 14 of 5.39±0.19 mg/mL, followed by F98 at 3.65±0.13 mg/mL, F108 at 3.29±0.06, and F88 at 2.35±0.05 mg/mL. Initial RES loading in SC method approaches 10 mg/mL in all the polymers, however, the micelles are unable to retain RES at this concentration for more than a few hours to a day. At the lower loading of 5 mg/mL a higher stability is seen in the Pluronic® micelles. In all micelles prepared by SC method, whether high or low loading, over a 14 day period the RES concentration in the micelles approached the equilibrium RES solubility.
Conclusion: Our results demonstrate that micelles prepared by SC result in meta-stable micelles when the amount of the compound loaded exceeds the equilibrium loading and the rate at which the compound in the micelles approaches equilibrium solubility is determined by the hydrophobicity of the compound and the hydrophile- lipophile balance (HLB) of the polymer.
Keywords: Drug loading and retention, micelle stability, pluronics®, polymeric micelles, resveratrol, simple equilibrium method, solvent casting method.
Graphical Abstract
Pharmaceutical Nanotechnology
Title:Evaluation of the Stability of Resveratrol Pluronic® Micelles Prepared by Solvent Casting and Simple Equilibrium Methods
Volume: 4 Issue: 2
Author(s): Deepa A. Rao, Brianna Cote, Michelle Stammet, Adel M. Al Fatease and Adam W.G. Alani
Affiliation:
Keywords: Drug loading and retention, micelle stability, pluronics®, polymeric micelles, resveratrol, simple equilibrium method, solvent casting method.
Abstract: Background: Many different methods have been developed to incorporate hydrophobic compounds into polymeric micelles, including simple equilibrium (SE) and solvent casting (SC). Thus far, no studies have compared the SE and SC methods for drug loading and stability.
Methods: Resveratrol (RES), a model hydrophobic compound, loaded in various Pluronics® (F88, F98, F108, and F127) is used to determine the differences between SE and SC methods.
Results: Micelles prepared by SE method demonstrated RES loading in proportion to their respective CMC values with F127 having the lowest CMC and highest loading at Day 14 of 5.39±0.19 mg/mL, followed by F98 at 3.65±0.13 mg/mL, F108 at 3.29±0.06, and F88 at 2.35±0.05 mg/mL. Initial RES loading in SC method approaches 10 mg/mL in all the polymers, however, the micelles are unable to retain RES at this concentration for more than a few hours to a day. At the lower loading of 5 mg/mL a higher stability is seen in the Pluronic® micelles. In all micelles prepared by SC method, whether high or low loading, over a 14 day period the RES concentration in the micelles approached the equilibrium RES solubility.
Conclusion: Our results demonstrate that micelles prepared by SC result in meta-stable micelles when the amount of the compound loaded exceeds the equilibrium loading and the rate at which the compound in the micelles approaches equilibrium solubility is determined by the hydrophobicity of the compound and the hydrophile- lipophile balance (HLB) of the polymer.
Export Options
About this article
Cite this article as:
A. Rao Deepa, Cote Brianna, Stammet Michelle, M. Al Fatease Adel and W.G. Alani Adam, Evaluation of the Stability of Resveratrol Pluronic® Micelles Prepared by Solvent Casting and Simple Equilibrium Methods, Pharmaceutical Nanotechnology 2016; 4 (2) . https://dx.doi.org/10.2174/2211738504666160428155355
DOI https://dx.doi.org/10.2174/2211738504666160428155355 |
Print ISSN 2211-7385 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Mass Spectrometry in the “Omics” Era
Current Organic Chemistry Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Brachytherapy: State of the Art and Possible Improvements
Anti-Cancer Agents in Medicinal Chemistry Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology Therapeutic Applications of Crocus sativus L. (Saffron): A Review
The Natural Products Journal Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis
Current Genomics Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Lactoferrin Suppresses Decreased Locomotor Activities by Improving Dopamine and Serotonin Release in the Amygdala of Ovariectomized Rats
Current Molecular Pharmacology Nanomedicines as Cancer Therapeutics: Current Status
Current Cancer Drug Targets Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents
Mini-Reviews in Medicinal Chemistry Intraoperative Localisation of Impalpable Breast Lesions Utilising the ROLLIS Technique Following Peritumoral <sup>99m</sup>Tc-colloid Sentinel Node Lymphoscintigraphy
Current Radiopharmaceuticals Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development
Current Cancer Drug Targets Purification and Characterization of a Lectin from the Indian Cultivar of French Bean Seeds
Protein & Peptide Letters Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews